Global Pharmaceutical and Biotechnology Outlook 2014 - Japan Pharma

Published: January 2014
No. of Pages: 141
    ReportsandReports

2014 will be marked as a transition year for the Japanese Pharma industry - the year is bound to be painful both for innovators and generic companies due to the new regulations.  We find these regulations to be 'decisive' in spurring generic penetration significantly, with the main beneficiary being the Japanese government (or society) and not the generic companies.  The implications of new price-reversions are going to have many facets and will change conventional business models.  We expect many support services industries - CMOs, CROs and other allied services industries to benefit from these structural changes, while API importers will suffer.  We also expect consolidation and M&A activities to spur in Japan.

Innovation Takes the Driver's Seat:  While the new regulations will change the current business philosophy of doing business in patent expired space (>45% to total Japan market), the policy makers also discourage 'me too' innovations at the same time. The regulators however tend to support the 'first time in the world' level innovations by providing 'innovation premiums'.  Japanese innovators will now become more serious and selective in their R&D approach.  Previous year the Japanese innovators have focused on acquiring assets in - autoimmune, orphan diseases and oncology fields (Annexure 5).  We expect this trend to prevail in the coming years.  We find some of the candidates to remain in the limelight in 2014 along with some new additions - Edoxaban (Daiichi Sankyo), Invokana (Mitsubishi Tanabe), Dolutegravir (Shionogi), BBI-608 (Dainippon Sumitomo), Vedolizumab (Takeda), Xtandi (Astellas), Nivolumab (Ono) to hand-pick a few of them. The reports explain detail analysis on these key candidates.

The 138 pages report contains the detailed discussion of Japan biopharmaceutical market – which includes- Our view on the impact of 2014 price cuts on generic companies and innovator companies and detailed discussion on key attributes (consolidation activities, potential of R & D pipeline candidates, generic threat in domestic Japan market etc…) of leading Japanese innovator companies- Astellas, Chugai, Daiichi Sankyo, Dainippon Sumitomo,  Eisai, Kyorin, Kyowa hakko Kirin, Mitsubishi Tanabe, Shionogi,  Takeda and  leading Japanese generic companies- Nippon Chemiphar, Sawai and Towa.

Published By: MP Advisors
Product Code: Access China Management Consulting Ltd14


Did you find what you are/were looking for ? If not, read below and browse through other relevant pages for similar market research reports OR get in touch with us through the form/contact info in your right navigation panel and well share relevant market report titles for you to explore.

Related Reports:

  • United States Bark Fines Market Report 2017

    Notes: Sales, means the sales volume of Bark Fines Revenue, means the sales value of Bark Fines This report studies sales (consumption) of Bark Fines in United States market, focuses on the top players, with sales, price, revenue and market shar...

  • United States Remote Health Delivery Market Report 2017

    Notes: Sales, means the sales volume of Remote Health Delivery Revenue, means the sales value of Remote Health Delivery This report studies sales (consumption) of Remote Health Delivery in United States market, focuses on the top players, with s...

  • United States Calcium Alginate Dressing Market Report 2017

    Notes: Sales, means the sales volume of Calcium Alginate Dressing Revenue, means the sales value of Calcium Alginate Dressing This report studies sales (consumption) of Calcium Alginate Dressing in United States market, focuses on the top player...

  • United States Biologics Market Report 2017

    Notes: Sales, means the sales volume of Biologics Revenue, means the sales value of Biologics This report studies sales (consumption) of Biologics in United States market, focuses on the top players, with sales, price, revenue and market share f...

  • United States Aspartame Free Proteins Market Report 2017

    Notes: Sales, means the sales volume of Aspartame Free Proteins Revenue, means the sales value of Aspartame Free Proteins This report studies sales (consumption) of Aspartame Free Proteins in United States market, focuses on the top players, wit...

  • United States Hybrid-Ceramic Dental CAD/CAM Material Market Report 2017

    Notes: Sales, means the sales volume of Hybrid-Ceramic Dental CAD/CAM Material Revenue, means the sales value of Hybrid-Ceramic Dental CAD/CAM Material This report studies sales (consumption) of Hybrid-Ceramic Dental CAD/CAM Material in United S...

  • United States Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report 2017

    Notes: Sales, means the sales volume of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Revenue, means the sales value of Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) This report studies sales (consumption) of Circulat...

  • United States Opioids Drugs Market Report 2017

    Notes: Sales, means the sales volume of Opioids Drugs Revenue, means the sales value of Opioids Drugs This report studies sales (consumption) of Opioids Drugs in United States market, focuses on the top players, with sales, price, revenue and ma...

  • United States Naloxone Market Report 2017

    Notes: Sales, means the sales volume of Naloxone Revenue, means the sales value of Naloxone This report studies sales (consumption) of Naloxone in United States market, focuses on the top players, with sales, price, revenue and market share for ...

  • United States Biosimilars Market Report 2017

    Notes: Sales, means the sales volume of Biosimilars Revenue, means the sales value of Biosimilars This report studies sales (consumption) of Biosimilars in United States market, focuses on the top players, with sales, price, revenue and market s...


Why ReportsnReports.com?

  • 500,000 market research reports and growing.
  • Top Fortune 500 Organizations trust us for research data.
  • 24/7 support on call as well as emails.
  • Your Details are safe with us.
  • Free support for your research requirements.
  • Report Delivery: Email
  • Delivery Time:
    • Upto 24 hrs - working days
    • Upto 48 hrs max - weekends and public holidays

Research Support / Custom Research

If this business study does not have the data and information analysis you need, contact us with your research requirements. We explore available market research reports to map your needs and share report titles with you. Alternatively, we can also offer custom research that suits your budget and timelines. Share your information requirements here.
Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441

Subscription Option

Using our subscription option, you get access to market research reports and industry data of Consumer Goods market as per your needs. Get the best of Consumer Goods research reports by utilizing your research budgets in an optimum way.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: